Azura Genomics

Executive Summary

Azura Genomics is a San Diego-based biotechnology company founded in 2017 that specializes in high-performance PCR and Real-Time PCR mastermixes, enzymes, and consumables for research and diagnostic applications. The company's product portfolio includes qPCR, cDNA synthesis, conventional PCR, genotyping, electrophoresis, and a wide range of lab consumables and equipment. Azura differentiates itself by offering reagents with best-in-class sensitivity, ease-of-use, and value, targeting both academic and commercial laboratories. As a private company, Azura operates in the competitive life sciences tools market, serving the growing demand for reliable and cost-effective molecular biology reagents. The company's focus on quality and performance positions it well for continued adoption among researchers and diagnostic developers.

Upcoming Catalysts (preview)

• Q3 2026Launch of next-generation qPCR mastermix with enhanced sensitivity70% success
• TBDStrategic partnership with a major diagnostic kit manufacturer40% success
• Q4 2026Expansion into new geographic markets (e.g., Europe, Asia)60% success